Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update for KN026 in patients with HER2-expressing gastric/gastroesophageal junction cancer; study status completed.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG [Phase 2]
Phase 2 clinical trial comparing perioperative immunotherapy to chemo-immunotherapy in advanced gastric cancer and esophagogastric junction …
-
CLINICAL_TRIALS research · 2024-03-12Clinical Trial Update: Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong
A cost-minimization analysis of gastric cancer treatments conducted in Hong Kong; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence [Phase 3]
Phase 3 clinical trial update evaluating prophylactic preoperative HIPEC to reduce peritoneal recurrence in advanced gastric cancer at high …
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia [Phase 2]
Phase 2 trial assessing whether curcumin can help prevent gastric cancer in patients with chronic atrophic gastritis or gastric intestinal m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating tirelizumab with chemotherapy for HER2-negative locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma. [Phase 3]
A phase 3 trial evaluating M108 plus CAPOX versus placebo plus CAPOX as first-line treatment for CLDN18.2-positive, HER2-negative, PD-L1 CPS…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial update evaluating SHR-1210 with trastuzumab, oxaliplatin, and capecitabine as neoadjuvant therapy for gastric adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS [Phase 3]
Phase 3 trial comparing adjuvant capecitabine to observation in curatively resected stage IB gastric cancer is currently recruiting under th…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study [Phase 1, Phase 2]
Clinical trial of durvalumab plus tremelimumab with paclitaxel for metastatic gastric cancer completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH [Phase 3]
Phase 3 trial updating adjuvant chemotherapy regimens for gastric cancer comparing Docetaxel/Capecitabine/Oxaliplatin versus Capecitabine/Ox…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update investigates fruquintinib in combination with SOX as neoadjuvant therapy for locally advanced gastric adenoc…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: Perioperative Chemo and Pembrolizumab in Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating perioperative chemotherapy with pembrolizumab for gastric cancer and gastroesophageal junction adenocarcin…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: TAS-102 and Anlotinib in ≥3 Lines mGC [Phase 2]
Phase 2 clinical trial update evaluating TAS-102 and Anlotinib in patients with gastric cancer who have received at least three prior lines …
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy plus camrelizumab as conversion therapy in metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial of FOLFOX-A for metastatic or unresectable gastroesophageal junction adenocarcinoma and gastric cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Docetaxel and Irinotecan in Gastric Cancer [Phase 2]
Phase 2 trial evaluating the combination of docetaxel and irinotecan in gastric/stomach cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression [Phase 2]
Phase 2 clinical trial evaluating disitamab vedotin with sintilimab and XELOX as perioperative treatment for resectable gastric cancer with …
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 clinical trial comparing modified XELOX plus sintilimab versus standard XELOX plus sintilimab as first-line therapy for HER2-negativ…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer [Phase 4]
A phase 4 trial update describing ramucirumab in combination with nab-paclitaxel, lobaplatin, and S-1 as neoadjuvant therapy for advanced ga…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen [Phase 3]
Phase 3 clinical trial update for SHR-A1811 in HER2-positive advanced gastric cancer or gastroesophageal junction adenocarcinoma after progr…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing SHR-1210 in combination with capecitabine plus oxaliplatin or apatinib for advanced gastric cancer has comp…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer [Phase 2]
Phase II study evaluating the combination of Irinotecan, POF (POFI), and tislelizumab in advanced gastric cancer is being investigated.
-
FDA approval · 2024-01-05FDA Approved: OXALIPLATIN — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for oxaliplatin submitted by Sagent Pharmaceuticals.